Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling

Myocardial oxidative stress and inflammation are key mechanisms in cardiovascular remodeling. C-type natriuretic peptide (CNP) is an endothelium-derived cardioprotective factor, although its effect on cardiac superoxide generation has not been investigated in vivo. This study tested the hypothesis t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasuhiro Izumiya, Satoshi Araki, Hiroki Usuku, Taku Rokutanda, Shinsuke Hanatani, Hisao Ogawa
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Vascular Medicine
Online Access:http://dx.doi.org/10.1155/2012/246058
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556298061742080
author Yasuhiro Izumiya
Satoshi Araki
Hiroki Usuku
Taku Rokutanda
Shinsuke Hanatani
Hisao Ogawa
author_facet Yasuhiro Izumiya
Satoshi Araki
Hiroki Usuku
Taku Rokutanda
Shinsuke Hanatani
Hisao Ogawa
author_sort Yasuhiro Izumiya
collection DOAJ
description Myocardial oxidative stress and inflammation are key mechanisms in cardiovascular remodeling. C-type natriuretic peptide (CNP) is an endothelium-derived cardioprotective factor, although its effect on cardiac superoxide generation has not been investigated in vivo. This study tested the hypothesis that suppression of superoxide production contributes to the cardioprotective action of CNP. Angiotensin II (Ang II) or saline was continuously infused subcutaneously into mice using an osmotic minipump. Simultaneously with the initiation of Ang II treatment, mice were infused with CNP (0.05 μg/kg/min) or vehicle for 2 weeks. The heart weight to tibial length ratio was significantly increased by Ang II in vehicle-treated mice. Treatment with CNP decreased Ang II-induced cardiac hypertrophy without affecting systolic blood pressure. Echocardiography showed that CNP attenuated Ang II-induced increase in wall thickness, left ventricular dilatation, and decrease in fractional shortening. CNP reduced Ang II-induced increases in cardiomyocyte size and interstitial fibrosis and suppressed hypertrophic- and fibrosis-related gene expression. Finally, CNP decreased Ang II-induced cardiac superoxide production. These changes were accompanied by suppression of NOX4 gene expression. Our data indicate that treatment with CNP attenuated Ang II-induced cardiac hypertrophy, fibrosis, and contractile dysfunction which were accompanied by reduced cardiac superoxide production.
format Article
id doaj-art-cc4d7cb66baa4ad5b6c6e01f59a15afc
institution Kabale University
issn 2090-2824
2090-2832
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Vascular Medicine
spelling doaj-art-cc4d7cb66baa4ad5b6c6e01f59a15afc2025-02-03T05:45:47ZengWileyInternational Journal of Vascular Medicine2090-28242090-28322012-01-01201210.1155/2012/246058246058Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac RemodelingYasuhiro Izumiya0Satoshi Araki1Hiroki Usuku2Taku Rokutanda3Shinsuke Hanatani4Hisao Ogawa5Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, JapanMyocardial oxidative stress and inflammation are key mechanisms in cardiovascular remodeling. C-type natriuretic peptide (CNP) is an endothelium-derived cardioprotective factor, although its effect on cardiac superoxide generation has not been investigated in vivo. This study tested the hypothesis that suppression of superoxide production contributes to the cardioprotective action of CNP. Angiotensin II (Ang II) or saline was continuously infused subcutaneously into mice using an osmotic minipump. Simultaneously with the initiation of Ang II treatment, mice were infused with CNP (0.05 μg/kg/min) or vehicle for 2 weeks. The heart weight to tibial length ratio was significantly increased by Ang II in vehicle-treated mice. Treatment with CNP decreased Ang II-induced cardiac hypertrophy without affecting systolic blood pressure. Echocardiography showed that CNP attenuated Ang II-induced increase in wall thickness, left ventricular dilatation, and decrease in fractional shortening. CNP reduced Ang II-induced increases in cardiomyocyte size and interstitial fibrosis and suppressed hypertrophic- and fibrosis-related gene expression. Finally, CNP decreased Ang II-induced cardiac superoxide production. These changes were accompanied by suppression of NOX4 gene expression. Our data indicate that treatment with CNP attenuated Ang II-induced cardiac hypertrophy, fibrosis, and contractile dysfunction which were accompanied by reduced cardiac superoxide production.http://dx.doi.org/10.1155/2012/246058
spellingShingle Yasuhiro Izumiya
Satoshi Araki
Hiroki Usuku
Taku Rokutanda
Shinsuke Hanatani
Hisao Ogawa
Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
International Journal of Vascular Medicine
title Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
title_full Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
title_fullStr Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
title_full_unstemmed Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
title_short Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
title_sort chronic c type natriuretic peptide infusion attenuates angiotensin ii induced myocardial superoxide production and cardiac remodeling
url http://dx.doi.org/10.1155/2012/246058
work_keys_str_mv AT yasuhiroizumiya chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling
AT satoshiaraki chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling
AT hirokiusuku chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling
AT takurokutanda chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling
AT shinsukehanatani chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling
AT hisaoogawa chronicctypenatriureticpeptideinfusionattenuatesangiotensiniiinducedmyocardialsuperoxideproductionandcardiacremodeling